# Fecal Microbiota Transplantation for Diabetes Mellitus Type II in Obese Patients

> **NCT02346669** · PHASE2 · UNKNOWN · sponsor: **Tel-Aviv Sourasky Medical Center** · enrollment: 30 (estimated)

## Conditions studied

- Diabetes Mellitus, Type 2
- Obesity

## Interventions

- **PROCEDURE:** gastroscopy
- **DRUG:** Fecal Microbiota Transplantation
- **OTHER:** high fat low fiber diet
- **OTHER:** sham diet
- **OTHER:** low fat high fiber diet

## Key facts

- **NCT ID:** NCT02346669
- **Lead sponsor:** Tel-Aviv Sourasky Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-04
- **Primary completion:** 2018-01
- **Final completion:** —
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2016-06-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02346669

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02346669, "Fecal Microbiota Transplantation for Diabetes Mellitus Type II in Obese Patients". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT02346669. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*